KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $97.9 million.

  • Neogenomics' Total Current Liabilities fell 6698.24% to $97.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.9 million, marking a year-over-year decrease of 6698.24%. This contributed to the annual value of $301.2 million for FY2024, which is 21280.22% up from last year.
  • Latest data reveals that Neogenomics reported Total Current Liabilities of $97.9 million as of Q3 2025, which was down 6698.24% from $100.1 million recorded in Q2 2025.
  • Neogenomics' 5-year Total Current Liabilities high stood at $301.2 million for Q4 2024, and its period low was $67.8 million during Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $92.9 million (2023), whereas its average is $131.5 million.
  • Over the last 5 years, Neogenomics' Total Current Liabilities had its largest YoY gain of 26461.35% in 2025, and its largest YoY loss of 6698.24% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Total Current Liabilities stood at $87.2 million in 2021, then grew by 3.1% to $89.9 million in 2022, then rose by 7.09% to $96.3 million in 2023, then surged by 212.8% to $301.2 million in 2024, then crashed by 67.51% to $97.9 million in 2025.
  • Its Total Current Liabilities stands at $97.9 million for Q3 2025, versus $100.1 million for Q2 2025 and $279.7 million for Q1 2025.